Baden, Switzerland

Thomas Marti

This inventor holds 1 USPTO granted patent. Top assignees: Celiac Sprue Research Foundation, Universitetet I Oslo. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas Marti. Retrieved from https://idiyas.com/inventor/thomas-marti-e0pihnil

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Thomas Marti

Introduction

Thomas Marti is a notable inventor based in Baden, Switzerland. He has made significant contributions to the field of medical research, particularly in relation to gluten-related disorders. His innovative work focuses on the mechanisms of immune response to gluten, which is crucial for understanding conditions such as Celiac Sprue and dermatitis herpetiformis.

Latest Patents

Thomas Marti holds a patent for a groundbreaking invention titled "Prolyl endopeptidase mediated destruction of T cell epitopes in whole gluten." This patent addresses the treatment of Celiac Sprue and dermatitis herpetiformis by interfering with HLA binding of immunogenic gluten peptides. The invention proposes that the antigenicity of gluten oligopeptides and the adverse effects caused by an immune response can be mitigated through the administration of an HLA-binding peptide inhibitor. These inhibitors are designed to be analogs of immunogenic gluten peptides, retaining the ability to bind tightly to HLA molecules while being proteolytically stable and incapable of activating disease-specific T cells. This innovative approach has the potential to significantly improve the quality of life for individuals affected by gluten-related disorders.

Career Highlights

Throughout his career, Thomas Marti has been associated with prominent organizations such as the Celiac Sprue Research Foundation and the University of Oslo. His work in these institutions has allowed him to collaborate with leading experts in the field, further enhancing his research and contributions to medical science.

Collaborations

Thomas has worked alongside notable colleagues, including Øyvind Molberg and Ludvig Sollid. Their combined expertise has fostered advancements in understanding gluten-related diseases and developing effective treatments.

Conclusion

Thomas Marti's innovative work in the field of gluten-related disorders exemplifies the impact of dedicated research and invention. His patent and collaborations highlight the importance of scientific inquiry in addressing complex health issues.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…